Business Wire

EGYPTIAN-TOURISM

Share
Egypt Beats Classic UK Holiday Destinations in Both Attractiveness and Price

The most popular foreign destinations for British holidaymakers are Italy and Spain. However, what many travellers do not know: For the price they spend on a holiday in these countries, they could experience more luxury and adventure in Egypt.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230216005515/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Winter in Egypt (Photo: Business Wire)

What Brits pay for their holidays abroad

Brits love to travel, but how much do they actually spend on their holidays? According to National Institute of statistics (Ine), the British invested an average of £1,0001 per person on a trip in 2021. However, a one-week stay including meals in a three-star hotel in Italy, for example, can cost up to £1,300 even in the low season. And that doesn't even include sightseeing, theatre tickets or museum visits.

In Egypt, two people can spend seven nights in a five-star hotel for less than the average price of a holiday in an Italian coastal region - all-inclusive, of course. The return flight from a major UK city is also included here. This leaves a lot of the budget for excursions and activities.

From paradisiacal beaches to the impressive expanse of the desert

Egypt has a lot to offer for all travelers - whether they are sun worshippers looking to relax on the beautiful coasts or culture vultures in search of ancient sites steeped in history. "Over the past two years, when we had restrictions on travel due to the pandemic, Egypt has been improving its travel infrastructure and working to expand what it has to offer visitors," says Amr El-Kady, managing director of the Egyptian Tourism Authority. "Even tourists who have visited Egypt before will now be able to discover many new options for things to do and interesting things to see. There are numerous, fantastic new accommodations available as domiciles."

For beach and sea lovers, the entire Egyptian coast is an ideal destination. You'll find plenty of white sandy beaches and warm, crystal-clear waters on both the Mediterranean and the Red Sea. From the beach resorts in Sharm El Sheikh on the Sinai Peninsula and Hurghada on Egypt's east coast, you can enjoy breathtaking views over the Red Sea. From here, you can also explore the mystical mountain regions inland. The Red Sea is also home to some of the most beautiful coral reefs in the world and can be explored by both amateur and professional divers. The Mediterranean coast from Alexandria to Marsa Matruh also beckons with turquoise waters and seemingly endless sandy beaches that invite you to swim, dive and sunbathe.

Those who prefer to discover and enjoy the incomparable beauty of the desert will not be disappointed either and can expect an experience like from 1001 Nights. In the Sinai desert, hiking and camel safaris offer an unforgettable experience for outdoor enthusiasts.

Tradition and history in the cities of the pharaohs

Among the most impressive historical sites is the magnificent city of Luxor with its spectacular sights such as the Valley of the Kings, the Temple of Karnak, and the legendary Luxor Temple. For a special experience, take a hot air balloon ride for a majestic view of the city on the Nile from above.

Fans of city trips should have Cairo on their agenda: In the Egyptian capital, millennia-old relics of antiquity meet the modern culture of the Middle East. The Great Sphinx and the Pyramids of Giza - the only remaining wonder of the ancient world - are unique buildings and an impressive testimony to ancient architecture. The history of the country is also presented in detail in the Egyptian Museum: It houses over 120,000 artefacts, including the treasures from Tutankhamun's tomb.

The Khan El Khalili bazaar is one of the oldest and most famous markets in the Middle East: here, holidaymakers can not only find authentic souvenirs but also enjoy the specialties of the local cuisine and get to know contemporary Egyptian culture.

Anyone looking for a multifaceted, historical and affordable travel destination should try Egypt to see for themselves the rich variety of this country with their own eyes and senses.

1 Ine (2022) Gasto de los turistas internacionales segun pais de residencia. Taken from: https://www.ine.es/jaxiT3/Datos.htm?t=10838#!tabs-tabla

– ENDE –

For further information:
https://www.experienceegypt.eg/

About the Egyptian Tourism Board

The Egyptian Tourism Board, established in 1981, is a regulatory body affiliated with the Ministry of Tourism. Its mission is to stimulate international tourism by promoting Egypt's rich history and civilization and highlighting the country's many tourist attractions. It also aims to promote domestic tourism, raise awareness of tourism throughout the country and strengthen the link between Egyptians and their heritage.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230216005515/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Welcomes Increased Equity Investment From L’Oréal8.12.2025 07:05:00 CET | Press release

L’Oréal to acquire an additional 10% stake in Galderma recognizing its scientific leadership in dermatology and long-term growth potential Ad hoc announcement pursuant to Art. 53 LR Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that L’Oréal Groupe intends to increase its equity investment in the company, acquiring an additional 10% stake from Sunshine SwissCo GmbH (a consortium led by EQT, Abu Dhabi Investment Authority (ADIA), and Auba Investment Pte. Ltd., acting as sellers). Following the transaction, which is subject to customary approvals, L’Oréal’s total shareholding in Galderma will rise to 20%, building on its initial investment made in August 2024. The transaction is expected to close in Q1 2026. In connection with this increased investment, Galderma will consider nominating two non-independent board candidates from L’Oréal, replacing the board members representing the consortium led by EQT, at the 2026 Annual General Meeting. Additio

Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 04:37:00 CET | Press release

The Challenge: Deepfakes undermine both the accuracy and fairness of AI face detection due to variations in human features.The Technology: Ant International’s AI model uses a novel ‘Mixture of Experts’-based Adversarial Debiasing approach to achieve superior fairness and accuracy across diverse demographics.The Impact: This advancement strengthens payment security, offering robust protection against deepfake fraud and enhancing eKYC compliance globally. Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the Nati

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release

Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi

Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse

Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye